Evidence-Based Medicine
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jul 7, 2017; 23(25): 4644-4653
Published online Jul 7, 2017. doi: 10.3748/wjg.v23.i25.4644
Figure 2
Figure 2 Chronic acid reflux esophagitis and effects of banhasasim-tang treatment. A: Normal, normal rats; B: Control, untreated CARE modeled-rats; C: BHSST, BHSST-treated (1 g/kg body weight per day) CARE modeled-rats. Histology of the non-CARE esophagus revealed thin epithelium with few inflammatory cells. Whereas, CARE esophagus showed mucosal thickening with basal cell hyperplasia and marked inflammatory cell infiltration. These histological changes were improved by BHSST treatment. H&E staining; original magnification × 200. CARE: Chronic acid reflux esophagitis; BHSST: Banhasasim-tang.